ArticleJournal of Korean medical science2019
Epidemiological Impact of the Korean National Immunization Program on Varicella Incidence.
Article in Journal of Korean medical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 15 citations in OpenAlex.
- Complementing conventional infectious disease surveillance with national health insurance claims data in the Republic of Korea.Scientific reports · 2019Trial
- Safety, immunogenicity, and effectiveness of the MAV/06 varicella vaccine: A comprehensive review of a new strain vaccine.Human vaccines & immunotherapeutics · 2026Review
- A cost benefit analysis of varicella vaccination in South Korea.Vaccine: X · 2024Article
- Clinical and radiological features of a cluster of immunocompetent adolescents with varicella pneumonia: a descriptive study.Journal of thoracic disease · 2024Article
- The impact of varicella vaccination: A 2005-2019 interrupted time series analysis.Human vaccines & immunotherapeutics · 2023Article
- Seroprevalence comparison of different varicella vaccines among Turkish children.Human vaccines & immunotherapeutics · 2022Article
- Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling.Human vaccines & immunotherapeutics · 2022Article
- Infectious Respiratory Diseases Decreased during the COVID-19 Pandemic in South Korea.International journal of environmental research and public health · 2021Article
- Article
- Letter to the Editor: Epidemiological Comments on the Effectiveness of the Varicella Vaccine in Korea.Journal of Korean medical science · 2020Article
- Protection against Severe Varicella Disease.Journal of Korean medical science · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The number of reported varicella cases is continuously increasing in Korea; however, associated medical utilization is declining. The ratio between varicella insurance claims and reports of passive infectious disease surveillance has gradually increased to > 80% since the second half of 2017. The recent increase in reported varicella cases is influenced by improved reporting. We calculated the varicella incidence and cumulative incidence in each birth cohort according to age. The cumulative incidence rate among children aged < 6 years in the birth cohort born after the National Immunization Program introduced the varicella vaccine was about 60% lower than among children born before.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.